Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemia

Bone Marrow Transplantation

Volumn 19, Issue 3, 1997, Pages 249-251

  Killick, S B ^a   Marsh, J C W ^a   Booth, J C ^a   Gordon Smith, E C ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Antilymphocyte globulin; Antithymocyte globulin; Aplastic anaemia; Liver function tests

Indexed keywords

ALANINE AMINOTRANSFERASE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APLASTIC ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; LIVER CELL; LIVER DISEASE; LIVER FUNCTION; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0031051494     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700653     Document Type: Article

References (21)

1. Young NS, Barrett AJ. The treatment of severe acquired aplastic anaemia. Blood 1985; 85: 3367-3377.
2. Shield CF, Cosimi AB, Tolkoff-Rubin N et al. Use of antithymocyte globulin for reversal of acute allograft rejection. Transplantation 1979; 28: 461-464.
3. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplantation in patients with aplastic anaemia. Blood 1994; 84: 941-949.
4. Doney KC, Weiden PL, Storb R et al. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomised trial comparing antithymocyte globulin and corticosteroids. Am J Haematol 1981; 11: 1-8.
5. Marsh JCW, Gordon-Smith EC. Treatment of aplastic anaemia with antilymphocyte globulin and cyclosporin. Int J Haematol 1995; 62: 133-144.
6. Bacigalupo A, Chappie M, Hows J et al. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (Mpred) with or without androgens: a randomised trial of the EBMT SAA Working Party. Br J Haematol 1993; 83: 145-151.
7. Bacigalupo A, Broccia G, Corda G et al. Antilymphocyte globulin, cyclosporin and granulocyte-colony stimulating factor in patients with acquired severe aplastic anaemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995; 85: 1348-1353.
8. Paquette RL, Tebyani N, Frane M et al. Long term outcome of aplastic anaemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 1995; 85: 283-290.
9. Rosenfeld SJ, Kimball J, Ving D et al. Intensive immunosuppression with antithymocyte globulin and cyclosporin as treatment for severe acquired aplastic anaemia. Blood 1995; 85: 3058-3065.
10. Schrezenmeier H, Marin P, Raghavachar A et al. Relapse of aplastic anaemia after immunosuppressive treatment: a report for the European Bone Marrow Transplant Group Severe Aplastic Anaemia Working Party. Br J Haematol 1993; 85: 371-377.
11. Schrezenmeier H, Hinterberger W, Hows J et al. Second immunosuppressive treatment of patients with aplastic anaemia not responding to the first course of immunosuppression (IS): a report from the Working Party on Severe Aplastic Anaemia of the EBMT. Bone Marrow Transplant 1995; 15 (Suppl. 2): 65a.
12. Hamblin M, Marsh JCW, Lawler M et al. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA identical sibling donors. Bone Marrow Transplant 1996; 17: 819-824.
13. Kojima S, Inaba J, Kando M et al. Unrelated donor marrow transplantation for severe acquired aplastic anaemia using cyclophosphamide, antithymocyte globulin and total body irradiation. Blood 1995; 85: 291-292.
14. Gluckman E, Auerbach AD, Horowitz MM et al. Bone marrow transplantation for Fanconi anaemia. Blood 1995; 86: 2856-2862.
15. Frickhofen N, Kaltwasser JP, Schrezenmeier H et al for the German Aplastic Anaemia Study Group. Treatment of aplastic anaemia with antilymphocyte globulin and methylprednisolone with or without cyclosporin. New Engl J Med 1991; 324: 1297-1303.
16. Camitta BM, Thomas ED, Nathan DG et al. Severe aplastic anaemia: a prospective study on the effect of early marrow transplantation on acute mortality. Blood 1976; 48: 63-70.
17. Balk AHMM, Meeter K, Simoons ML et al. Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study. Transplant Int 1992; 5 (Suppl. 1): 5476-5479.
18. Slakey DP, Johnson CP, Callaluce RD et al. A prospective randomised comparison of quadruple versus triple therapy for first cadaver transplant with immediate function. Transplantation 1993; 56: 827-831.
19. Raffade P, Pouteil-Noble C, Lefrancois N et al. Influence of a randomised monoclonal or polyclonal programme of therapy on cytomegalovirus infection in kidney transplantation. Transplant Proc 1991; 23: 1361-1362.
20. American Hospital Formulary Service Drug Information 1995, vol. 8.
21. Greco B, Bielory L, Stephany D et al. Antithymocyte globulin reacts with many normal human cell types. Blood 1983; 62: 1047-1054.